Skip to main content
SpringerLink
Log in

Editorial: Priorities in future research in prostate cancer screening

  • Editorial Introduction
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002; 94(13): 981–990.

    PubMed  Google Scholar 

  2. Hankey BF, Feuer EJ, Clegg LX, et al. Cancer Surveillance Series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999; 91(12): 1017–1024.

    PubMed  Google Scholar 

  3. Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. Cancer surveillance series: Interpreting trends in prostate cancer - Part III: Quantifying the link between population oristate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 1999; 91(12): 1033–1039.

    PubMed  Google Scholar 

  4. Bartsch G, Horninger W, Klicker H, et al. Prostate Cancer mortality after introduction of prostate-specific antigen mass screening in the federal state of Tyrol, Austria. Urology 2001; 58: 417–424.

    PubMed  Google Scholar 

  5. Oliver SE, May MT, Gunnell D. International trends in prostate cancer mortality in the PSA-era. Int J Cancer 2001; 92(6): 893–898.

    PubMed  Google Scholar 

  6. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995; 274(8): 626–631.

    PubMed  Google Scholar 

  7. Lu-Yao GL, Yao SL. Population-based study of longterm survival in patients with clinically localised prostate cancer. Lancet 1997; 349: 906–910.

    PubMed  Google Scholar 

  8. Draisma G, Boer R, Otto SJ, et al. Lead times and overdetection due to prostate-specific antigen screening: Estimates from the European Randomized Study of Screening for Prostate Cancer (ERSPC). J Natl Cancer Inst 2003; 95(12): 868–878.

    PubMed  Google Scholar 

  9. Lu-Yao, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle and Connecticut. Br Med J 2002; 325(7367): 740.

    Google Scholar 

  10. Perron L, Moore L, Bairati I, Bernard PM, Meyer F. PSA screening and prostate cancer mortality. CMAJ 2002; 166(5): 586–591.

    PubMed  Google Scholar 

  11. Gohagan JK, Prorok PC, Hayes RB, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO). Screening Trial of the National Cancer Institute: History, organization, and status. Control Clin Trials (suppl) 2000; 21(6S): 249S–406S.

    Google Scholar 

  12. de Koning HJ, Auvinen A, Berenguer Sanchez A, et al. Large-scale randomized prostate cancer screening trials; program performances in the ERSPC-and PLCO-trials (European randomized screening for prostate cancer-and prostate, lung, colorectal and ovary cancer trials). Int J Cancer 2002; 97(2): 237–244.

    PubMed  Google Scholar 

  13. Zappa M, Ciatto S, Bonardi R, Mazzotta A. Overdiagnosis of prostate carcinoma by screening: An estimate based on the results of the Florence screening pilot study. Annals of Oncology 1998; 9(12): 1297–1301.

    PubMed  Google Scholar 

  14. McGregor M, Hanley JA, Boivin JF, McLean RG. Screening for Prostate cancer: Estimating the magnitude of overdetection. CMAJ 1998; 159(11): 1368–1372.

    PubMed  Google Scholar 

  15. Holmberg L, Bill-Axelson A, Helgesen F, et al. Scandinavian Prostatic Cancer Group Study Number 4. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347(11): 781–789.

    PubMed  Google Scholar 

  16. Hakama M, Stenman UH, Aromaa A, Leinonen J, Hakulinen T, Knekt P. Validity of the prostate specific antigen test for prostate cancer screening: Followup study with a bank of 21,000 sera in Finland. J Urol 2001; 166(6): 2189–2191; discussion 2191-2192.

    PubMed  Google Scholar 

  17. Carter HB. Rationale for earlier and less frequent prostate cancer screening. Urology 2001; 58(5): 639–641.

    PubMed  Google Scholar 

  18. Ross KS, Carter HB, Pearson JD, Guess HA. Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection. JAMA 2000; 284(11): 1399–1405.

    PubMed  Google Scholar 

  19. Smith RA, Mettlin CJ, Davis KJ, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000; 50: 34–49.

    PubMed  Google Scholar 

  20. Fang F, Metter EJ, Landis P, et al. Low levels of prostate specific antigen predict the long term risk of prostate cancer. Urology 2001; 58: 411–416.

    PubMed  Google Scholar 

  21. Choo R, DeBoer G, Klotz L, et al. PSA doubling time of prostate carcinoma managed with watchful observation alone. Int J Radiat Oncol Biol Phys 2001; 50(3): 615–620.

    PubMed  Google Scholar 

  22. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002; 60(5): 826–830.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Erasmus MC, Rotterdam, The Netherlands

    Fritz H. Schröder

Authors
  1. Fritz H. Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schröder, F.H. Editorial: Priorities in future research in prostate cancer screening. Eur J Epidemiol 18, 1021–1024 (2003). https://doi.org/10.1023/A:1026152002332

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026152002332

Search

Navigation